Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-powered Experiences

Medidata announced that Caidya, a mid-sized global CRO operating in over 50 countries, expanded its partnership by investing in additional Medidata solutions including CTMS and Clinical Data Studio. Medidata now supports over 80% of Caidya's trials. The page states Clinical Data Studio is designed to use AI to cut review cycles by up to 80%, while the integrated CTMS provides AI-powered insights for faster decisions, aimed at connecting workflows across therapeutic areas such as oncology, rare diseases, and pediatrics.

Medidata is a Dassault Systèmes company supplying the clinical-trial EDC and data platform (Rave) most sponsors and CROs already run live trials on, now with an AI layer built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.